Semi-quantitative Multispectral Optoacoustic Tomography (MSOT) for volumetric PK imaging of gastric emptying  by Morscher, Stefan et al.
Photoacoustics 2 (2014) 103–110Research Article
Semi-quantitative Multispectral Optoacoustic Tomography (MSOT) for
volumetric PK imaging of gastric emptying
Stefan Morscher, Wouter H.P. Driessen, Jing Claussen, Neal C. Burton *
iThera Medical, GmbH, Munich, Germany
A R T I C L E I N F O
Article history:
Received 14 November 2013
Received in revised form 17 April 2014
Accepted 18 June 2014
Available online 27 June 2014
Keywords:
Multispectral Optoacoustic Tomography
(MSOT)
Photoacoustic imaging
Indocyanine Green
In vivo imaging
Pharmacokinetics
Gastric emptying
A B S T R A C T
A common side effect of medication is gastrointestinal intolerance. Symptoms can include reduced
appetite, diarrhea, constipation, GI inﬂammation, nausea and vomiting. Such effects often have a
dramatic impact on compliance with a treatment regimen. Therefore, characterization of GI tolerance is
an important step when establishing a novel therapeutic approach.
In this study, Multispectral Optoacoustic Tomography (MSOT) is used to monitor gastrointestinal
motility by in vivo whole body imaging in mice. MSOT combines high spatial and temporal resolution
based on ultrasound detection with strong optical contrast in the near infrared. Animals were given
Indocyanine Green (ICG) by oral gavage and imaged by MSOT to observe the fate of ICG in the
gastrointestinal tract. Exponential decay of ICG signal was observed in the stomach in good correlation
with ex vivo validation. We discuss how kinetic imaging in MSOT allows visualization of parameters
unavailable to other imaging methods, both in 2D and 3D.
 2014 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
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Lifestyle and medication can have a signiﬁcant impact on
gastric emptying. For example, alcohol, tobacco and nicotine
reduce gastric motility, whereas beta-adrenergic receptor antago-
nists and erythromycin have prokinetic properties [1]. These
effects can inﬂuence the exposure to medication by increasing or
decreasing bioavailability and can impact compliance to the
therapeutic regimen. A variety of methods have been employed to
interrogate the gastrointestinal (GI) system to characterize the
effect of xenobiotics. Some of them involve invasive surgeries
where smooth muscle electrical activity is measured by attaching
electrodes and miniaturized strain-gauge transducers directly to
muscle tissue [2–4]. Similarly, sonomicrometry can be employed
by attaching multiple piezoelectric transducers directly to tissue,
and characterizing motion by determining the time-interval
between the detection of acoustic waves at the different transducers
[5]. Muscle activity can also be measured with ex vivo organotypic
muscle tissue cultures, allowing tight control over experimentalAbbreviations: MSOT, Multispectral Optoacoustic Tomography; ICG, Indocyanine
Green.
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stomach contents ex vivo [7,8], or determine the mobilization of
dyes fed to the animal throughout the gut via histology [9,10].
Non-invasive in vivo methods have also been developed to
probe gastric function. For example, glass beads can be fed to mice,
and the colonic expulsion time can be taken as a metric of whole
gut transit time [11]. Similarly, dyes can be used to assess the
gut latency by observing the ﬁrst appearance of the agent in
the stool [12]. Other metrics such as food intake, fecal pellet
weight and percentage of animals exhibiting diarrhea can also
be used as gross indicators of gastric intolerance.
In vivo imaging has also been used to measure gastric motility.
For instance, radiopaque or radiolabeled substances can be
administered, and the distribution of the agent can be visualized
through X-ray photography [13] or through gamma scintigraphy
[14]. Alternatively, ﬂuorescence reﬂectance imaging has been used
to show the distribution of administered agents throughout the gut
[15]. However, these imaging approaches have been limited to
dorsal views of the animal where the distinction between stomach,
liver and intestines is challenging due to photon scattering along
the detection path. High resolution imaging of optical contrast in
biological tissue requires an approach to overcome optical tissue
scattering. Acoustic waves are less subject to scattering, indicating
that a hybrid imaging modality can obtain higher resolution in
whole body imaging. Acousto-optic imaging [16,17] uses spatiallyrticle under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
Fig. 1. Near infrared absorption spectra of hemoglobin as the dominant background
absorber (de-oxygenated and oxygenated) and ICG [45], with highlighted
optoacoustic imaging wavelengths (700 nm, 730 nm, 760 nm, 800 nm, 850 nm,
900 nm).
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turn be detected with a photodetector, hence allowing one to
obtain a more accurate measure of tissue absorption. However, the
portion of light being modulated and thereafter detected is
comparably small, and is still affected by absorption in tissue,
limiting sensitivity of the modality. The presented work uses the
photoacoustic effect to generate sound waves, which are far less
subject to scattering in tissue. While some approaches exist that
exploit this effect using microwave excitation in the near-ﬁeld
[18–20] or amplitude modulated light sources to employ
optoacoustic imaging in the frequency domain [21,22], time
domain optoacoustic imaging is the most commonly used
implementation. With existing implementations in photoacoustic
microscopy [23–26] and high-resolution tomography using
frequencies above 10 MHz [27–29], this paper applies lower
detection frequencies for whole body optoacoustic tomography
[30–32].
Multispectral Optoacoustic Tomography (MSOT) [33,34] is an in
vivo optical imaging modality that, in the presented study, enables
non-invasive assessment of gastric emptying with high spatial and
temporal resolution. The animal is illuminated with short, near
infrared (NIR) light pulses at different wavelengths generated by a
tunable laser. This light is absorbed by tissue-intrinsic chromo-
phores such as hemoglobin or melanin or administered exogenous
contrast agents with distinct absorption spectra in the near
infrared, such as Indocyanine Green (ICG). Importantly, MSOT does
not rely on emitted ﬂuorescence like other optical imaging
modalities, but mere absorption of light is enough to give rise to
the photoacoustic effect. Following absorption, part of the
absorbed energy is converted to heat, causing a transient
thermoelastic expansion that generates an acoustic wave. This
acoustic wave can be detected by an array of ultrasound
transducers to produce an optoacoustic image representing an
acoustic pressure map. In the chosen implementation, such a map
depicts a cross-section of a mouse and, using assumptions on light
ﬂuence, can be converted to a map of optical absorption. This
allows discrimination between signal intensities in multiple organs;
for example, the stomach and liver in the current study. Image
acquisition at multiple wavelengths and subsequent spectral
analysis [35] allows the determination of the spatial distribution
of NIR-absorbing agents in distinction to tissue-intrinsic contrast in
many scenarios of applied research [34,36–40]. An optoacoustic
pressure map can be generated within microseconds based on
simultaneous detection of signals from all elements of the
transducer array, allowing a high temporal resolution only limited
by the feasible laser repetition rate. Unlike conventional optical
imaging, optoacoustic imaging maintains its high spatial resolution
also in deep tissue, since acoustic waves can traverse tissue with
almost undiminished quality, whereas photons are subject to a
comparatively high amount of scattering [41,42].
MSOT has further been used in this regard for imaging of
dynamic contrast enhancement with extrinsic contrast agents in
the brain [36,37] and various metabolic organs [43,44]. To take this
concept further, the presented study uses dynamic contrast
enhanced imaging for investigation of stomach emptying.
2. Methods
2.1. Animals
Eight week old nude Foxn1 female mice were used in
compliance with the Helmholtz Zentrum Mu¨nchen Animal Care
and Use committee. The mice were fasted for a brief period
before the experiment to allow comparable results. During the
experiment the animals were under isoﬂurane anesthesia (1.8%
at 0.8 l/min).2.2. Imaging agents
Indocyanine Green (ICG) (Pulsion Medical Systems, Germany)
was selected due to its well-studied ﬂuorescence and optoacoustic
properties [45]. Its absorption proﬁle in plasma is shown in Fig. 1
(at 6.5 mM). It is an FDA-approved, water-soluble, inert anionic
tricarbocyanine dye. For gavage studies, 10 nmol of ICG was mixed
into a 200 ml solution containing 1% Cremophor (v/v), 25% glycerol
(v/v) in water, and the volume was injected into the animal via a
feeding tube immediately prior to MSOT imaging. This vehicle was
found to be well tolerated by the animals in earlier studies [46].
2.3. Experimental MSOT imaging system
The experimental MSOT imaging setup used for most of this
study was engineered at the Institute of Biological and Medical
Imaging (IBMI) at Helmholtz Zentrum Mu¨nchen and will be
referred to as ‘‘experimental imaging system’’ in the rest of this
paper. Earlier versions of this system have been described
elsewhere in detail [47,48]. A tunable optical parametric oscillator
(OPO) pumped by an Nd:YAG laser (Opotek Inc., Carlsbad, CA)
provides excitation pulses with a duration of 9 ns at wavelengths
from 680 nm to 980 nm at a repetition rate of 10 Hz. A light strip of
about 8 mm width on the mouse is evenly illuminated from 10
arms of a ﬁber bundle arranged at an angle of 13 degrees to the
imaging plane (see Fig. 2). The laser delivers a peak energy of
100 mJ at 730 nm, which is distributed across 6 cm2 on the mouse
surface, resulting in a radiant exposure of 18.3 mJ/cm2 which is
well below the maximum permissible exposure (MPE) in humans
as deﬁned in EN60825-1. In order to correct the acquired
multispectral data, the laser’s energy proﬁle was measured at
the wavelengths used for the acquisition of MSOT data. A
cylindrically focused 128 element ultrasound transducer array
at a center frequency of 5 MHz covers an angle of 270 degrees
around the sample to create cross-sectional images. The photo-
acoustic signals in the mV range captured by all transducer
elements are digitized simultaneously using specialized acquisi-
tion electronics (Falkenstein Microsysteme GmbH, Taufkirchen,
Germany) at a sampling rate of 40 megasamples/s. Mice are
submerged in a water tank in a horizontal position in a holder and
are wrapped in a thin polyethylene membrane to prohibit direct
contact between water and mouse but still allow for acoustic
coupling. Anesthesia and oxygen are supplied through a breathing
mask. The mouse and holder can be translated using a linear stage
(IAI Industrieroboter GmbH, Schwalbach, Germany) to enable
imaging of multiple transverse slices. In order to create an image at
one wavelength, signals from 20 subsequent excitation pulses
Fig. 2. Illumination and detection geometry in the imaging chamber. The animal is
translated along the z-axis in order to enable acquisition of multiple transverse
cross sections in the x–y plane.
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and animal motion as well as to improve signal-to-noise ratio
(SNR).
In the second part of the study, imaging was performed using an
MSOT inVision 256-TF small animal scanner [48] (iThera Medical
GmbH, Munich, Germany) that will from here onwards be
referenced as ‘‘MSOT inVision system’’. It is an improved and
commercially available implementation of the imaging systemFig. 3. Combined visualization of anatomical and molecular images: Optoacoustic images
700 nm, (b) 800 nm, (c) 900 nm; (d) biodistribution of ICG obtained through multispe
representing anatomical structures in grayscale with probe biodistribution information fr
showing reference anatomy see Fig. 4b.detailed above, featuring a 256 element transducer array at the
same center frequency, but using a reduced radius for the active
surface to create a toroidal focusing that allows for an increased
ﬁeld of view in the imaging plane. It also uses a speciﬁcally
developed, proprietary laser system (InnoLas Laser GmbH,
Krailling, Germany) of equal energetic characteristics and pulse
width, but in contrast to the prototype detailed above allows fast
wavelength tuning in between laser pulses. It also features an
integrated laser pulse energy correction that enables the correction
of each laser pulse with its measured energy, inherently
compensating for the laser’s wavelength-dependent energy
proﬁle. This reduces the need for averaging and thus greatly
enhances imaging speed (one multispectral image in 7 s using 10
averages and 7 wavelengths), allowing for acquisition of multiple
slices per time point to capture kinetic processes in volumetric
data sets as demonstrated in the study.
The vertical lines in Fig. 1 depict the excitation wavelengths at
which in vivo MSOT measurements are made, representing
wavelengths with distinctive absorption patterns relative to the
other background chromophores depicted in the graph.
2.4. Image reconstruction and spectral unmixing
Images in Figs. 3 and 4 were reconstructed using a standard
backprojection algorithm [49], and three-dimensional images in
Fig. 5 were reconstructed using the interpolated model-matrix
inversion [50]. Both were applied from within the ViewMSOT
software suite supplied with the iThera Medical system. After
image reconstruction, linear spectral unmixing was applied to
detect and separate signals from photo-absorbing tissue
elements, such as hemoglobin, or ICG [35,51]. For each pixel
in the image, the method ﬁts the total measured optoacoustic
spectrum to the known absorption spectra of oxy- and
deoxyhemoglobin and that of the agent to be detected. This
produces individual component images, each visualizing the
bio-distribution of the respective absorber. In the presented
study this process is speciﬁcally employed to be able to separate
changes in the ICG signal from changes produced by hemoglo-
bin, e.g. a difference in perfusion. are shown 5 min after oral gavage of ICG. (a–c) Single-wavelength images at l = (a)
ctral unmixing (e) overlay of single-wavelength background image (l = 900 nm)
om the ICG component in color. For an annotated cryoslice image of a similar mouse
Fig. 4. MSOT imaging of gastric emptying. Panel (a) shows the ICG signal distribution at multiple time points after oral gavage of an ICG-containing solution. MSOT images
show a single-wavelength optoacoustic image (grayscale, 900 nm) as an anatomical reference with an overlay of multispectrally resolved ICG signal (green). Panel (b) shows
ex vivo sectioning of animals sacriﬁced at 15 and 75 min post ICG administration, with an RGB image showing reference anatomy and location of the ﬂuorescent ICG shown in
green. Panel (c) shows the quantiﬁcation of MSOT signals from mice (n = 3) (open circles), with modeled data shown as a black line. Red squares indicate ﬂuorescence
measured ex vivo in mice (n = 1).
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In order to also visualize deep structures such as the stomach
correctly in 3D, the images in Fig. 6 have been corrected with an
approximate light ﬂuence model based on the ﬁnite elements
approach applied to generate the forward model in [52,53]. It was
based on a simple, cylindrical FEM mesh adapted to the size of the
mouse and the imaged volume, while assuming homogeneous
distribution of scattering and absorption (model parameters:
background tissue oxygenation = 70%, m800 nma ¼ 0:3 cm1,
m0s ¼ 10 cm1) within the subject. Based on its simplicity, this
model does not allow quantiﬁcation of signal but merely
represents a mode to adequately visualize deep seated signals.
Data in Figs. 3 and 4 has not been corrected for locally varying
light ﬂuence, hence signal intensities will be varying with depth. In
awareness of this fact, regions of interests have been selected at
similar size (25 mm2) and depth (2–6 mm). The signal ampli-
tudes in Fig. 4c were calculated from the mean of the selected areaFig. 5. Pharmacokinetic model employed on the MSOT-derived concentration–time
proﬁles and parameters describing the modeled curve shown in Fig. 4c.in the ICG component image and were individually normalized to
the peak intensity of each animal for the modeling.
2.6. Pharmacokinetic modeling
Pharmacokinetic modeling of the concentration–time curves
was performed using a two-compartmental open body model in
WinNonLin (Certara L.P., St. Louis, MO, USA) [54]. This pharmaco-
kinetic model was chosen based on the evaluation of the
Goodness-of-Fit (correlation between observed and predicted
values; residual plots). As in all compartmental models, homoge-
nous distribution of compound within each compartment and a
non-changing volume of each compartment is assumed for the
modeling.
2.7. Three-dimensional visualization
The three-dimensional renderings presented in Fig. 5 were
created outside the ViewMSOT software supplied with the iThera
Medical system by using the shear warp rendering algorithm [55]
from the viewer_3d toolkit (version 11) available through MATLAB
Central File Exchange [56]. Logarithmic alpha mapping was
applied in order to be able to visualize signals deep inside the animal.
2.8. Cryosectioning with planar ﬂuorescence imaging
For whole-body, ex vivo, cross-sectional ﬂuorescence imaging
of probe biodistribution, a Leica cryostat (CM 1950, Leica
Microsystems, GmbH, Wetzlar, Germany) was retroﬁtted with a
ﬂuorescence imaging system [57] with excitation at 740 nm and
emission captured with a 780 nm long pass ﬁlter. The exposure
time was adjusted dynamically with an upper limit of 7s to
optimize the dynamic range and stored with the image. The
evaluated images were divided with their respective exposure
time in order to put them on a comparable scale. Prior to
measurements a test target was imaged in order to calibrate
Fig. 6. Three-dimensional MSOT kinetics: Volumetric representation of anatomical information in grayscale combined with molecular information overlaid in color at
different time points (t = 5 min, t = 20 min, t = 50 min, t = 80 min), both in a 3-D rendering (top row) and in two exemplary cross-sections in stomach and intestines (bottom
two rows). ICG clears from the stomach and accumulates in the intestines and the liver.
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nation between samples.
The samples were cut at equidistant intervals of 500 mm
throughout the region of the stomach. One slice was selected from
each sample based on visual similarity with the structures
displayed in the MSOT images as well as a representative amount
of ICG that matched the adjacent slices.
3. Results
3.1. Separation from background absorbers
In order to evaluate the biodistribution of ICG from MSOT images,
spectral unmixing needs to be performed to separate the agent
signal from the background signals. The ﬁrst row of images in Fig. 3
shows exemplary cross-sectional optoacoustic images at three of the
measured wavelengths, acquired on the experimental imaging
system. Imaging for all mice shown in this study was performed in an
area of the animal that shows both the stomach and the liver. The
second row shows the component image for ICG resulting from
spectral unmixing, showing the distinct contributions of the
individual absorber separated from the strong hemoglobin back-
ground visible in the ﬁrst row. In order to better visualize the bio-
distribution of ICG, the respective component is overlaid with a
green color map onto a non-speciﬁc single-wavelength image in
grayscale to combine probe and background tissue information.3.2. PK imaging of stomach emptying
In order to observe the kinetic process of stomach emptying,
imaging was performed continuously to produce a time series
of images with the experimental imaging system. The ﬁrst
row of Fig. 4 shows three images at different time points
after the oral gavage of ICG. It clearly shows a decrease of
speciﬁc ICG signal in the stomach area and at the same time an
increase of ICG signal in the liver area following the known
hepatobiliary clearance pathways of ICG after systemic absorp-
tion. Ex vivo ﬂuorescence cryoslice data from different
animals undergoing the same procedure show the same
behavior, which is depicted in the second row of Fig. 4. Most
interestingly, the signal decay in the stomach through clearance
can be observed by deﬁning a region of interest in the stomach
and following the mean signal intensity of the unmixed ICG
component in the selected area. The graph in Fig. 4c shows the
respective data over time from animals undergoing the same
procedure (n = 3; open circles). This data can be ﬁtted to a two-
compartmental model (Fig. 5). Ex vivo cryoslice validation
conﬁrms the results observed by MSOT imaging at 3 time points
(Fig. 4; red squares).
The MSOT-derived concentration–time proﬁles were modeled
to a two-compartmental open body model (Fig. 5) to account for
the biphasic gastric emptying behavior observed. The rate
constants describing the modeled PK curve are found in Fig. 5.
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stomach and an elimination half-life of 36.3 min.
3.3. Volumetric PK imaging
Using the MSOT inVision imaging system, it was possible to
visualize the same process in multiple cross-sectional slices,
allowing the volumetric visualization of gastric emptying with a
temporal resolution of 5 min. Selected time points are shown in
Fig. 6 with a three-dimensional rendering (ﬁrst line) and
exemplary cross-sectional images from two locations along the
z-axis representing the stomach/liver area and an intestinal area
(gray lines). All time points are combined in a video (see Video 1).
Equivalent to the observations made In Fig. 4, signal from ICG in
the stomach area is decreasing with time, as ICG is cleared from
the stomach toward the intestines. As the stomach empties into
the intestines, some of the ICG is likely absorbed in the proximal
duodenum, accounting for the increased liver signal following
hepatobiliary excretion.
4. Discussion
As MSOT imaging is non-invasive, it is possible to repeatedly
image individual animals, enabling longitudinal imaging, e.g. to
characterize a baseline rate of gastric emptying against which
comparisons can be made following treatment. This approach can
potentially minimize the impact of biological variability between
mice, and allows the use of fewer animals to make a statistically
signiﬁcant observation. Indeed, since it is not necessary to sacriﬁce
the animal to obtain a measurement, it is also possible that the
animals may be permitted to recover from drug treatment before
being used again, depending on the nature of the toxicant or
pharmaceutical being tested. This could also aid in the characteri-
zation of chronic exposure to xenobiotics and related effects on
gastric emptying and thus provide insights for pre-clinical research
in characterization of novel pharmaceuticals. However, the
presented study cannot be easily translated to clinical settings
due to limitations of penetration depth.
The non-invasive aspect of MSOT-based gastric emptying
determination is also important in terms of allowing the
investigator access to biological processes in the intact animal.
Organotypic cultures or ex vivo observations can sometimes be
subject to artifacts related to euthanasia, or the necessity of
making conclusions on tissue outside of its native environment
[58]. Through the use of in vivo imaging, one can make a direct
conclusion on gastric motility without disrupting the gastrointes-
tinal system.
In addition, the acquisition of single-wavelength data at 10
images per second frame rate, or multispectral data at up to 2
images per second, yields sample-rich data sets. In comparison to
ex vivo studies, pharmacological modeling with MSOT requires far
fewer animals. Traditionally, kinetic studies are performed by
sacriﬁcing many animals at multiple time points, giving rise to
study cohorts with dozens of animals per treatment group. Instead,
as in this study, a full pharmacological proﬁle can be determined
using MSOT with a signiﬁcantly smaller number of mice, driving
down the ﬁnancial investment of the study, as well as the time
required to complete it.
For the determination of gastric emptying in vivo, optoa-
coustic imaging has advantages over traditional optical imaging.
First, as acoustic waves scatter far less compared to photons, it is
possible with MSOT imaging to maintain resolution at depth. In
contrast, optical imaging detects photons which have propagat-
ed through and have been scattered by tissue [52]. Without a
mechanism to model the complex scattering of light, it is
impossible to precisely determine the origin of optical signals atdepth. Hence, spatial resolution of optical imaging greatly
suffers in determining dynamics of the gut. In addition, the
tomographic approach to optoacoustic imaging presented in
this manuscript demonstrates the utility of cross-sectional
versus projection-based planar imaging in discriminating vari-
ous parts of the gastrointestinal system from adjacent organs,
such as the stomach and liver. In projection based approaches, it
can be hard to determine from a single view angle whether a
superﬁcial weak signal or a deeper strong signal is being
detected. Therefore, one must rotate the animal repeatedly and
acquire data from multiple view angles in order to increase
conﬁdence in signal localization, thereby increasing the effort
and time required to conduct an experiment. With MSOT
imaging, this is not necessary since the cross-sectional view
provides a clear visualization of the spatial distribution of
injected agents, while with the recent technological advances
whole-body imaging by translation of the animal is feasible
while maintaining high temporal resolution. Fast multispectral
imaging thus allows the sequential acquisition of volumetric
datasets to enable complex three-dimensional representation of
biodistribution of agents. While the presented horizontally
rendered view of the animal is very similar to what is known
from projection-based planar optical imaging approaches, the
additional cross-sectional images provide evidence of the actual
spatial distribution of the agent in the animal. Apart from the
inherent spatial and temporal resolution, the combination of
tissue and probe information can be very useful in various ﬁelds
to study biodistribution and kinetic processes in mice. The
additional feature of probe multiplexing [40] by combining
labels with different absorption peaks paves the road for even
more advanced scenarios, such as the simultaneous injection of
a functionalized agent and a control in the same animal or, in
the case of the described application, simultaneously determin-
ing gastric emptying rates of liquids and solids.
While MSOT imaging can also provide very sensitive detection
of signal in deep tissues, absolute quantiﬁcation of signals
remains still the most challenging aspect of optoacoustic imaging
based on the need to accurately model light ﬂux in deep tissues. It
must be noted that in the presented study only the three-
dimensional dataset shown in Fig. 6 was corrected using an
approximate light ﬂuence model for visualization of signals in
deeper regions. The graph in Fig. 4 was created from regions that
were intentionally selected with similar depth and size and
therefore under the assumption of equal illumination conditions.
While this holds for the presented imaging scenario for
comparisons between animals in a similar imaging setting, this
certainly poses a challenge for other applications that require
comparisons between organs with very different optical param-
eters within a single animal.
In summary, MSOT offers important new features in small
animal gastrointestinal imaging. It was demonstrated that
anatomical and physiological parameters were visualized in high
spatial and temporal resolution through gut cross-sections and
volumes. In this study, non-targeted ICG was used to measure
gastric emptying, but it would similarly be possible to conduct
such an experiment with a molecular probe to detect, for example,
inﬂammatory epitopes in the gut. This imaging ability may bring a
new dimension in small animal GI research by allowing imaging of
physiological and possibly molecularly targeted signals with high
resolution; a capacity not available with optical or nuclear imaging
techniques. We expect that the combination of the imaging
performance exhibited by small animal MSOT together with new
molecular probes will enable new insights into gastrointestinal
function and disease.
As a modality, however, optoacoustic imaging is not limited
only to the preclinical setting but has shown very promising
S. Morscher et al. / Photoacoustics 2 (2014) 103–110 109perspectives in many scenarios in a clinical setting such as
mammography [59], superﬁcial imaging using handheld detectors
[60–62] and intravascular as well as endoscopic imaging [63–65].
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